Marine Biotechnology Market (By Type: Bio Active Substance, Bio Materials; By Technology: Isolation and Cultivation of Microorganisms, Culture-Independent Techniques; By Application; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and

The global marine biotechnology market was valued at USD 5.7 billion in 2021 and it is predicted to surpass around USD 10.59 billion by 2030 with a CAGR of 7.13% from 2022 to 2030.

Marine Biotechnology Market Size 2021 to 2030

Marine Biotechnology is the field of science of producing products from aquatic organisms with the approaches of biotechnology, cell biology, molecular biology, and bioinformatics. It deals with the development of pharmaceutical drugs, enzymes and chemical products by exploring the ocean and marine resources. It is also referred to as blue biotechnology. It includes the use of techniques like bioremediation, bioprocessing, bioharvesting, and aquaculture with the application of bioreactors.

Applications of marine biotechnology include medicine, biofuels, environment, health management, reproduction, and nutrition. For example, Reproduction: Production of fish gonadotropin hormone by crude pituitary gland preparation using recombinant DNA technology, Nutrition: Transfer of glucose and hexokinase genes in the carnivorous fish for enhancing the carbohydrate uptake metabolism, Health improvement and management: Use of polymerase chain reaction (PCR) in disease diagnosis. The National Institute of Ocean Technology of India has prepared anti-aging cosmetics from deep-sea bacteria in July 2021.

As per the research, the application of sea-based ingredients in agriculture and cosmetics is in high demand fostering the marine biotechnology market growth. The nutritional supplements made from marine-derived products are in increasing demand leading to the growth of the marine biotechnology market. Discoveries and progress in the fields of aquaculture, fishery, and drug discovery development is the key driver for the market growth. Recently, Bluu Biosciences received funding for the production of fish products from cell culture. An increase in the demand and awareness of using aquatic organisms for healthy management paves way for the industry growth. 

The market is segmented by type, technology, application, end-user, and region. The type segment is bifurcated into bio active substances and bio materials. The technology segment is bifurcated into isolation and cultivation of microorganisms, and culture-independent techniques. The application segment is based on aquaculture and food products, environment and human health, and drug discovery. The end-user segment is fragmented by food industry, pharmaceutical and biotechnology industry, chemical industry, and cosmetic industry. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. 

Europe has the major share of the marine biotechnology market due to the government's support to use sea-based products. Thus the funding and investments by the government are the driving factor for the growth of the market. North America also has better and developed healthcare and research facilities coupled with biotechnology companies producing marine-based products, thus driving industry growth.

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 5.7 billion
Revenue Forecast by 2030 USD 10.59 billion
Growth rate from 2022 to 2030 CAGR of 7.13%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Type, Technology, Application, End-user, Region
Companies Covered

Sea Run Holdings Inc., NEB, Nofima, Lonza Group Ltd., Sams, Tequesta Bioventures, PharmaMar S.A., Abbott Laboratories, New England Biolabs Inc., Qingdao Codo International Ltd., Earthrise Nutritionals, NovaMatrix, GlycoMar Ltd., SEPPIC, Nutrex Hawai Inc., Royal DSM N.V., Biotech Marine, Aquapharm, Marinova, Prolume Ltd., Cyanotech Corporation, Aker Biomarine, CP Kelco US Inc.

 

Key Players

  • Sea Run Holdings Inc.
  • NEB
  • Nofima
  • Lonza Group Ltd.
  • Sams
  • Tequesta Bioventures
  • PharmaMar S.A.
  • Abbott Laboratories
  • New England Biolabs Inc.
  • Qingdao Codo International Ltd.
  • Earthrise Nutritionals
  • NovaMatrix
  • GlycoMar Ltd.
  • SEPPIC
  • Nutrex Hawai Inc.
  • Royal DSM N.V.
  • Biotech Marine
  • Aquapharm
  • Marinova
  • Prolume Ltd.
  • Cyanotech Corporation
  • Aker Biomarine
  • CP Kelco US Inc.

Market Segmentation

  • By Type
    • Bio Active Substance
    • Bio Materials
  • By Technology
    • Isolation and Cultivation of Microorganisms
    • Culture-Independent Techniques
  • By Application
    • Aquaculture and Food Products
    • Environment & Human Health
    • Drug Discovery
  • By End-user
    • Food Industry
    • Pharmaceutical and Biotechnology Industry
    • Chemical Industry
    • Cosmetic Industry
  • By Region
    • North America 
    • Europe 
    • Asia-Pacific
    • Latin America
    • Middle East And Africa

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Marine Biotechnology Market 

5.1. COVID-19 Landscape: Marine Biotechnology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Marine Biotechnology Market, By Type

8.1. Marine Biotechnology Market, by Type, 2022-2030

8.1.1. Bio Active Substance

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Bio Materials

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Marine Biotechnology Market, By Technology

9.1. Marine Biotechnology Market, by Technology, 2022-2030

9.1.1. Isolation and Cultivation of Microorganisms

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Culture-Independent Techniques

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Marine Biotechnology Market, By Application 

10.1. Marine Biotechnology Market, by Application, 2022-2030

10.1.1. Aquaculture and Food Products

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Environment & Human Health

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Drug Discovery

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Marine Biotechnology Market, By End-user 

11.1. Marine Biotechnology Market, by End-user, 2022-2030

11.1.1. Food Industry

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Pharmaceutical and Biotechnology Industry

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Chemical Industry

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Cosmetic Industry

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Marine Biotechnology Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2017-2030)

12.1.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.4. Market Revenue and Forecast, by End-user (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End-user (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End-user (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End-user (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End-user (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End-user (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End-user (2017-2030)

Chapter 13. Company Profiles

13.1. Sea Run Holdings Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. NEB

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Nofima

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Lonza Group Ltd.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Sams

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Tequesta Bioventures

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. PharmaMar S.A.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Abbott Laboratories

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. New England Biolabs Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Qingdao Codo International Ltd.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers